The global malaria diagnostics market size was valued at USD 144.6 million in 2015. Growing demand for these diagnostics from malaria endemic countries is expected to be the key factor driving the growth of the MD industry. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and sub-tropical regions. Globally, around 3.2 billion populace still remains at the increased risk of the disease. As per the WHO estimates, September 2015, 214 million malarial cases were detected in 2015, and the number of fatalities was estimated to be 438,000 during the same period.
Technological advancements in the industry are further expected to boost the MD industry during the forecast period. Increasing demand and rising need for high-quality and cost-efficient diagnostic methods are likely to trigger advancements in the industry. These advancements are expected to further assist in enhancing the work flow and improving efficiency with minimal errors, thus driving demand for malaria diagnostics in the market.
However, an increasing number of countries in the malaria elimination phase is one of the key factors restricting market growth. Several countries including Iraq, Oman, the United Arab Emirates, Georgia, Armenia, and Argentina among others have reported zero indigenous malaria cases. Additionally, there are also few countries such as Algeria and El Salvador that have reported less than 10 indigenous cases in 2014. Furthermore, growing demand for low-cost diagnostic tests is likely to hinder market growth over the forecast period.
Africa malaria diagnostics market, by technology, 2012 - 2022 (USD Million)
On the basis of technology, the market is categorized into microscopy, Rapid Diagnostic Tests (RDTs), and others. RDT malaria diagnostic market in terms of value was estimated to account for the largest share of over 63% in the year 2015.
RDTs are mainly used, where microscopy examination is not feasible, especially in remote areas with limited access to quality microscopy services or poor healthcare infrastructure. Additionally, they are easy-to-use, require low-skilled labor force, and also provides less turnaround time. Thus, the aforementioned factors are expected to be some of the key attributes for the growth of the RDT diagnostics at a global level.
The key regions analyzed in the report are Africa, East Mediterranean, America, Europe, South-East Asia, and Western Pacific. In terms of volume, the African MD industry is estimated to account for the largest share and is projected to grow up to 60% by 2022. This growth is attributable to the increasing demand for malaria diagnostics, majorly RDT owing to the highest disease burden in the region.
South-East Asia is expected to hold the second position globally, India leading the industry. The Indian MD market, by volume, is projected to grow at a significant CAGR of 3.85% during the review period. Several other countries in the region have witnessed a significant decrease in the malarial incidences. For instance, presently, Sri Lanka is in the prevention of reintroduction phase, whereas Democratic People’s Republic of Korea and Bhutan are in the pre-elimination phase.
Competitive Market Share Insights
The key players dominating the RDT malaria diagnostics industry are Alere Inc., Access Bio Inc., and Premier Medical Corporation, among others. These players accounted for over 80% of the market share in 2014. The companies are majorly engaged in technological advancements, new product development, joint ventures, partnerships, and collaborations to maintain their position in industry. For instance, in March 2015, Standard Diagnostics/Alere announced the extension of their collaboration with FIND that includes the development of an innovative RDT for malaria as well as human African trypanosomiasis or sleeping sickness.
Please discuss your specific research requirements, for a tailor made consumer centric report.
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.